The Valley Desk

Healthcare research from Johnson & Johnson, page 4

A filtered view. Show the full list.

Refine

817 publications and 7 software projects · listings 73–96

Listings

  1. ArticleCell

    Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  2. ArticleCell reports

    Combining genotoxic gut bacterial strains increases tumor burden and accelerates onset in a germ-free mouse model of colon carcinogenesis

    Listed An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  3. ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    No Impact of Low-Dose Nivolumab Addition to JNJ-73763989 on Hepatitis B Surface Antigen Declines in Chronic Hepatitis B: The OCTOPUS-1 Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  4. ArticleCell host & microbe

    Defined human Clostridia consortia reverse colitis via dual effects of tryptophan metabolites on microbiota and immunity

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  5. ArticleCHEST pulmonary

    Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  6. ArticleCJC open

    Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  7. ArticleClinical therapeutics

    Antipsychotic Treatment Pathways, Real-World Adherence, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Schizophrenia Treated With Once-Monthly, Once-Every-Three-Months, and Once-Every-Six-Months Paliperidone Palmitate in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  8. Clinical trial reportClinical lung cancer

    Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  9. Clinical trial reportClinical lung cancer

    Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  10. ArticleClinical lymphoma, myeloma & leukemia

    Relative Effectiveness of Talquetamab Versus Real-World Physician's Choice Treatment Regimens in Patients With Relapsed/Refractory Multiple Myeloma: Updated Results From an Indirect Treatment Comparison

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  11. ReviewClinical lymphoma, myeloma & leukemia

    Real-World Evidence on Ibrutinib in First-Line Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma: A Comprehensive Review

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  12. ReviewClinical lymphoma, myeloma & leukemia

    Choosing Wisely in First Relapse of Multiple Myeloma: Expert Insights on Treatment Selection

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  13. ArticleClinical lymphoma, myeloma & leukemia

    Real-World Treatment Patterns and Outcomes for Patients With Relapsed/Refractory Multiple Myeloma and Prior Exposure to Lenalidomide and Proteasome Inhibitors in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  14. ReviewClinical lymphoma, myeloma & leukemia

    Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Clinical careAdded

  15. ArticleClinical lymphoma, myeloma & leukemia

    Teclistamab Response- and Relapse-Related Immune Correlates in the MajesTEC-1 China Cohort

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  16. ReviewDrug metabolism and disposition: the biological fate of chemicals

    A review on integrated machine learning and deep learning driven artificial intelligence models for pharmacokinetics and toxicokinetics predictions, and their application

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  17. ArticleDrug metabolism and disposition: the biological fate of chemicals

    Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development

    Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  18. ArticleDrug metabolism and disposition: the biological fate of chemicals

    Metabolism and excretion pathways of CD388, a novel drug-fragment crystallizable conjugate for prevention of seasonal or pandemic influenza

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  19. ArticleDrug metabolism and disposition: the biological fate of chemicals

    In vitro reversible enzyme inhibition assays to predict drug-drug interactions: Current state and industry perspective from the IQ Consortium Enzyme Inhibition Working Group

    Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  20. ArticleDrug metabolism and disposition: the biological fate of chemicals

    Breaking the 1% unbound threshold: an IQ consortium whitepaper on the evaluation of plasma protein binding of highly bound compounds

    Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson, Merck & Co. Affiliation source

    Biomedical and life sciencesAdded

  21. ReviewDrug metabolism and pharmacokinetics

    Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  22. Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)

    Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  23. ReviewEULAR rheumatology open

    From pixels to prediction: improving imaging through AI in rheumatology

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Medical imagingAdded

  24. Clinical trial reportESMO open

    Full enrollment results from cohort 1 of the phase III randomized THOR trial of erdafitinib versus chemotherapy in FGFR-altered advanced urothelial carcinoma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded